Gustavo Plasencia, MD
Colon & Rectal Surgery · Miami, FLNPI 1386723567
Payments from drug & device makers
What this record shows
This record is dominated by education: $32,000 of the $46,366 with a category attached, or 69.0%. Intuitive Surgical accounts for 77.7% of it on its own, with 28 other manufacturers making up the rest. Reporting peaked in 2021 at $11,163 and has fallen 95.3% since, to $522 in 2025.
Across 165 payments — averaging $281.00 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Intuitive Surgical$36K
- Johnson & Johnson$5K
- Medtronic$2K
- Integra Lifesciences Corporation$740
- Davol Inc.$655
- KARL Storz Endoscopy-america$540
- plus $2K from 23 others
What the payments were for
- Consulting fees$3,5358%
- Speaking & faculty fees$2,0004%
- Travel & lodging$1440%
- Food & beverage$7,97517%
- Education$32,00069%
- Gifts$850%
- Other$6271%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Intuitive Surgical | 70 | $36,005 |
| Johnson & Johnson(2 entities) | 14 | $4,519 |
| Medtronic(2 entities) | 5 | $2,094 |
| Integra Lifesciences Corporation | 10 | $740 |
| Davol Inc. | 10 | $655 |
| KARL Storz Endoscopy-america | 6 | $540 |
| Conmed Corporation | 6 | $430 |
| Innocoll Pharmaceuticals Limited | 8 | $175 |
| Braintree Laboratories, Inc. | 8 | $162 |
| Innovation Technologies Inc | 1 | $135 |
| Cook Medical LLC | 2 | $126 |
| Medical Device Business Services, Inc. | 1 | $125 |
| Baxter Healthcare | 1 | $122 |
| TELA Bio, Inc. | 3 | $77 |
| Stryker | 1 | $74 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 3 | $46 |
| BD | 1 | $43 |
| AbbVie | 2 | $43 |
| Axonics, Inc. | 2 | $38 |
| Hologic Sales And Service, LLC | 2 | $32 |
| Tempus AI, Inc | 1 | $27 |
| Ferring Pharmaceuticals Inc. | 1 | $26 |
| Smith+Nephew | 1 | $24 |
| Concordia Pharmaceuticals Inc. | 1 | $23 |
| Kerecis Limited | 1 | $21 |
| Shire North American Group Inc | 1 | $21 |
| Pacira Pharmaceuticals Incorporated | 1 | $16 |
| Olympus America Inc. | 1 | $15 |
| Redhill Biopharma Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Da Vinci Surgical System$33,913
- Echelon Flex$3,645
- ECHELON ENDOPATH$3,535
- VersaOne$2,000
- ACell$531
- PHASIX$139
- Irrisept$135
- HOPKINS$134
- Phasix Mesh$133
- FLOSEAL$122
- VISTASEAL Fibrin Sealant (Human)$120
- ENDOPATH ETS Articulating Linear Cutter$116
- AIRSEAL$115
- Cook Medical Surgery$107
How this compares
$46,366 in reported general payments places this provider in the 85th percentile of 157 colon & rectal surgery providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| LinzessLinaclotide | 11 | $6,564 |
| Sod Sulf-Potass Sulf-Mag SulfSodium, Potassium,mag Sulfates | 52 | $2,978 |
| Peg 3350-ElectrolyteSodium Chloride/Nahco3/Kcl/Peg | 83 | $1,580 |
| Hydrocortisone | 17 | $190 |
| Gavilyte-GPeg3350/Sod Sulf,bicarb,cl/Kcl | 12 | $161 |
| Metronidazole | 39 | $103 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieLinzess | $43 | $6,56411 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 157 colon & rectal surgery providers in Florida.
Other colon & rectal surgery in Miami
- Henry LujanMiami$378K
- Luis HernandezMiami$220K
- Laurence SandsMiami$47K
- Marianna ZeichenMiami$44K
- Andrea MadiedoMiami$38K
- Eduardo KrajewskiMiami$29K
- Marcos SzomsteinMiami$22K
- Gustavo RubioMiami$14K
- Mark SolimanAltamonte Springs$872K
- Eduardo Parra DavilaWest Palm Beach$577K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.